The collaboration leverages uBriGene’s LVV Turbo platform for GMP lentiviral vector manufacturing and regulatory support.

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a ...

CAR T-cell therapy is a personalized treatment that uses a patient’s own immune cells to fight cancer, making it effective but unsuitable for mass production, which increases the cost. The complex ...

Avantor AVTR recently entered into a strategic partnership with BlueWhale Bio to accelerate innovation in CAR-T cell therapy manufacturing. The collaboration merges Avantor’s bioprocessing expertise ...

For years, one of the most powerful weapons against certain blood cancers, called CAR-T cell therapy, has required an ...

As demand for precision medicine accelerates, CAR T and CAR Treg cell therapies are emerging as crucial tools in the fight against cancer and autoimmune diseases. For Thomas Fellner, PhD, head of ...

The company is establishing commercial production capabilities to fuel plans to launch autologous CAR T cell therapies in ...

Scientists have developed a method to reprogram cancer-fighting immune cells directly inside the body, potentially ...

Often diagnosed when surgery is no longer an option, pancreatic cancer is one of the most difficult cancers to treat and has ...